BioGaia AB (FRA:BGLA)
€ 9.115 -0.035 (-0.38%) Market Cap: 931.59 Mil Enterprise Value: 835.03 Mil PE Ratio: 31.83 PB Ratio: 6.64 GF Score: 95/100

Q3 2022 Biogaia AB Earnings Call Transcript

Oct 21, 2022 / 07:30AM GMT
Release Date Price: €7.82 (-1.70%)
Operator

Welcome to the BioGaia Audiocast with Teleconference Q3 2022. (Operator Instructions) Today, I am pleased to present CEO, Isabelle Ducellier; and CFO, Alexander Kotsinas. Speakers, please begin.

Isabelle Valerie Ghislaine Ducellier;publ;CEO;President
BioGaia AB

()-&

Thank you, and welcome, everybody, to BioGaia's Q3 interim management statement. And indeed, we are -- I'm kind of happy with the Q3 sales and figures in general. That's the fifth quarter in a row with double-digit growth, and Q3 shows a strong -- net sales increased by 48% and the year-to-date at 33% for (inaudible) SEK 30 million. The operating profit is increasing by 40% at SEK 94 million, and our operating margin is at 36%. And Alex will comment the cash flow later on.

Next page, please. If you go through the key events. So outside of the 2 reverse profit warning, we did one for Q1 and one for Q2 -- sorry, one for Q2 and one for Q3. We have been announcing that we just opened a pilot plant at Eslöv, so (inaudible) production, where we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot